Join
Live feed
·
INSIDERFilingvia Quantisnow
Acrivon Therapeutics Inc. logo

Chief Financial Officer Levy Adam D. sold $1,793 worth of shares (1,142 units at $1.57), decreasing direct ownership by 2% to 66,008 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRV (Acrivon Therapeutics Inc.) and more on Quantisnow.